Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 6

Zeitschriftenartikel

Viegas, Edna O.; Kroidl, Arne; Munseri, Patricia J.; Missanga, Marco; Nilsson, Charlotte; Tembe, Nelson; Bauer, Asli; Joachim, Agricola; Joseph, Sarah; Mann, Philipp; Geldmacher, Christof; Fleck, Sue; Stohr, Wolfgang; Scarlatti, Gabriella; Aboud, Said; Bakari, Muhammad; Maboko, Leonard; Hoelscher, Michael; Wahren, Britta; Robb, Merlin L.; Weber, Jonathan; McCormack, Sheena; Biberfeld, Gunnel; Jani, Ilesh; Sandstrom, Eric und Lyamuya, Eligius (2018): Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design.
In: PLOS One 13(11), e0206838 [PDF, 1MB]

Ake, Julie A.; Schuetz, Alexandra; Pegu, Poonam; Wieczorek, Lindsay; Eller, Michael A.; Kibuuka, Hannah; Sawe, Fredrick; Maboko, Leonard; Polonis, Victoria; Karasavva, Nicos; Weiner, David; Sekiziyivu, Arthur; Kosgei, Josphat; Missanga, Marco; Kroidl, Arne; Mann, Philipp; Ratto-Kim, Silvia; Eller, Leigh Anne; Earl, Patricia; Moss, Bernard; Dorsey-Spitz, Julie; Milazzo, Mark; Ouedraogo, G. Laissa; Rizvi, Farrukh; Yan, Jian; Khan, Amir S.; Peel, Sheila; Sardesai, Niranjan Y.; Michael, Nelson L.; Ngauy, Viseth; Marovich, Mary und Robb, Merlin L. (2017): Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost. In: Journal of infectious Diseases, Bd. 216, Nr. 9: S. 1080-1090

Bauer, Asli; Podola, Lilli; Mann, Philipp; Missanga, Marco; Haule, Antelmo; Sudi, Lwitiho; Nilsson, Charlotta; Kaluwa, Bahati; Lueer, Cornelia; Mwakatima, Maria; Munseri, Patricia J.; Maboko, Leonard; Robb, Merlin L.; Tovanabutra, Sodsai; Kijak, Gustavo; Marovich, Mary; McCormack, Sheena; Joseph, Sarah; Lyamuya, Eligius; Wahren, Britta; Sandstrom, Eric; Biberfeld, Gunnel; Hölscher, Michael; Bakari, Muhammad; Kroidl, Arne und Geldmacher, Christof (2017): Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen. In: Journal of Virology, Bd. 91, Nr. 18, e00730-17

Joachim, Agricola; Bauer, Asli; Joseph, Sarah; Geldmacher, Christof; Munseri, Patricia J.; Aboud, Said; Missanga, Marco; Mann, Philipp; Wahren, Britta; Ferrari, Guido; Polonis, Victoria R.; Robb, Merlin L.; Weber, Jonathan; Tatoud, Roger; Maboko, Leonard; Hoelscher, Michael; Lyamuya, Eligius F.; Biberfeld, Gunnel; Sandström, Eric; Kroidl, Arne; Bakari, Muhammad; Nilsson, Charlotta und McCormack, Sheena (2016): Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial.
In: PLOS ONE 11(5), e0155702 [PDF, 1MB]

Nadai, Yuka; Ahmed, Mohamed I. M.; Joseph, Sarah; Missanga, Marco; Bauer, Asli; Cope, Alethea V.; Joachim, Agricola; Reimer, Ulf; Pollakis, Georgios; McCormack, Sheena; Tatoud, Roger; Shattock, Robin J.; Robb, Merlin; Sandstroem, Eric; Hölscher, Michael; Bakari, Muhammad; Maboko, Leonard; Kroidl, Arne; Weber, Jonathan; Geldmacher, Christof und Held, Kathrin (2016): Env-specific IgG Responses Induced by Identical and None-identical Immunogen Prime-boost Vaccination Strategies Target Different Antigenic Regions. In: Aids Research and Human Retroviruses, Bd. 32: S. 392

Munseri, Patricia. J.; Kroidl, Arne; Nilsson, Charlotta; Joachim, Agricola; Geldmacher, Christof; Mann, Philipp; Moshiro, Candida; Aboud, Said; Lyamuya, Eligius; Maboko, Leonard; Missanga, Marco; Kaluwa, Bahati; Mfinanga, Sayoki; Podola, Lilly; Bauer, Asli; Godoy-Ramirez, Karina; Marovich, Mary; Moss, Bernard; Hoelscher, Michael; Gotch, Frances; Stoehr, Wolfgang; Stout, Richard; McCormack, Sheena; Wahren, Britta; Mhalu, Fred; Robb, Merlin L.; Biberfeld, Gunnel; Sandstrom, Eric und Bakari, Muhammad (2015): Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial.
In: PLOS ONE 10(4), e0119629 [PDF, 787kB]

Diese Liste wurde am Sat Mar 23 21:51:08 2024 CET erstellt.